- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 174-188 of
1,124 results
2 Notice Power of Attorney: Notice Power of Attorney
Document
IPR2023-00724, No. 2 Notice Power of Attorney - Notice Power of Attorney (P.T.A.B. Mar. 16, 2023)
|
|
Cite Document
1 Petition as filed: Petition as filed
Document
IPR2023-00724, No. 1 Petition as filed - Petition as filed (P.T.A.B. Mar. 16, 2023)
|
|
Cite Document
No. 23-1
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 23-1 (N.D.W.Va. May. 9, 2022)
|
|
Cite Document
No. 12-1
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 12-1 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
No. 10-1
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 10-1 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
No. 9-1
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 9-1 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
No. 11-1
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 11-1 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
No. 2-6
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-6 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-7
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-7 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-19
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-19 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-17
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-17 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-13
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-13 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-3
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-3 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-2
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-2 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-18
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-18 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
